Mechanistic studies reveal that DLL3-high SCLC tumors exhibit STAT3-driven PD-L1 upregulation, creating an immunosuppressive niche resistant to immune checkpoint inhibitors (ICIs) (56). The gene discussed is CD274; the disease is small cell lung carcinoma.